|
PerkinElmer announces availability of HER2Sense preclinical imaging agent
PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the availability of the HER2Sense preclinical imaging agent, to support breast cancer discovery research into personalized medicine.
More... |
| All times are GMT -7. The time now is 05:40 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021